Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 USD | -4.67% | -4.67% | +8.51% |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oren Gilad
CEO | Chief Executive Officer | 56 | 22-04-30 |
John Hamill
DFI | Director of Finance/CFO | 60 | 23-01-29 |
Zeev Weiss
PRN | Corporate Officer/Principal | 62 | 22-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 14-12-31 |
John Henneman
BRD | Director/Board Member | 62 | 19-07-31 |
Rifat Pamukcu
BRD | Director/Board Member | 66 | 22-04-30 |
Jean Bizzari
BRD | Director/Board Member | 69 | 23-08-22 |
Oren Gilad
CEO | Chief Executive Officer | 56 | 22-04-30 |
Marc Duey
BRD | Director/Board Member | 68 | 22-04-30 |
Richard Peters
CHM | Chairman | 61 | 20-06-29 |
Director/Board Member | 70 | 22-04-30 | |
Gabriela Gruia
BRD | Director/Board Member | 67 | 23-05-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 56,227 | 0 | 0 | 83.50 % |
Stock B | 1 | 5,430,215 | 4,534,187 ( 83.50 %) | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.51% | 29.05M | |
+2.00% | 42.59B | |
+8.46% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.96% | 24.81B | |
-24.05% | 18.17B | |
+29.27% | 12.05B | |
-2.77% | 11.7B | |
+7.04% | 11.1B |
- Stock Market
- Equities
- APRE Stock
- Company Aprea Therapeutics, Inc.